Cyrusone Inc (CONE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 251,500 | 225,000 | 221,300 | 206,600 | 196,900 |
| Total expenses | 231,800 | 213,200 | 206,500 | 186,400 | 169,900 |
| Operating Income | 19,700 | 11,800 | 14,800 | 20,200 | 27,000 |
| Interest Expense | 21,100 | 23,700 | 25,300 | 25,800 | 22,800 |
| Other Income | -8,500 | 101,100 | -96,700 | -36,600 | 102,700 |
| Pre-tax Income | -9,900 | 89,200 | -107,200 | -42,200 | 106,900 |
| Income Tax | -1,400 | -200 | -1,400 | 200 | 1,000 |
| Net Income Continuous | -8,500 | 89,400 | -105,800 | -42,400 | 105,900 |
| Net Income | $-8,500 | $89,400 | $-105,800 | $-42,400 | $105,900 |
| EPS Basic Continuous Ops | -0.08 | 0.83 | -1.09 | -0.43 | 1.07 |
| EPS Basic Total Ops | -0.08 | 0.82 | -1.09 | -0.43 | 1.07 |
| EPS Diluted Continuous Ops | -0.08 | 0.82 | -1.07 | -0.43 | 1.07 |
| EPS Diluted Total Ops | -0.08 | 0.82 | -1.08 | -0.43 | 1.06 |
| EBITDA(a) | $122,900 | $115,100 | $113,700 | $105,400 | $105,700 |